You may have seen claims in the media and online that GLP-1 medications, sometimes called “weight loss injections”, can reduce endometriosis symptoms. Although some people may report feeling better while taking them, there is currently no clinical evidence that GLP-1 medications treat endometriosis pain or symptoms, and they should not be viewed as treatments for endometriosis.
What are GLP-1 medications?
GLP-1 agonists mimic a natural hormone released after eating. They can help people feel fuller for longer, slow stomach emptying and improve blood sugar control. Tirzepatide (Mounjaro) also acts on a second hormone involved in appetite and glucose regulation.
Examples available in the UK include:
- Semaglutide (Wegovy, Ozempic and Rybelsus)
- Tirzepatide (Mounjaro)
What are they licensed for?
In the UK, GLP-1 medications are licensed for:
- Type 2 diabetes
- Obesity, or being overweight with related health risks
A licence means a medication has been assessed and approved as safe and effective for a specific use.
They are not licensed for cosmetic weight loss or for treating endometriosis.
There is no clinical evidence to show that GLP-1 medications are safe or effective for managing endometriosis pain or symptoms. Personal experiences shared online do not replace properly conducted research.
These medicines should only be used for clear medical reason, under licensing and with guidance from a healthcare practitioner.
Contraception and pregnancy
GLP-1 medications should not be taken during pregnancy or while trying to conceive because there is not enough safety information about their effects on a developing baby. Anyone who could become pregnant should use effective contraception while taking them.
Because GLP-1 medicines slow stomach emptying, they can affect how some oral medicines are absorbed. This may reduce the effectiveness of the contraceptive pill. Those taking GLP-1 medications should consider non-oral contraceptive methods.
As always, with any decisions, questions, or concerns about medical treatment of any kind, please consult your healthcare team.
Download our information guide on Endometriosis and GLP-1s here.